Skip to main content

Table 5.

Tumor response

Response 200 mg bid (n = 13) 400 mg bid (n = 14) Total (n = 27)
Partial response  1  0  1 (3.7%)
Stable disease 10 11 21 (77.8%)
Progressive disease  1  2  3 (11.1%)
NA  1  1  2 (7.4%)

NA, not assessed because these patients did not complete cycle 1.